AR060349A1 - Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del trastorno de ansiedad generalizada - Google Patents

Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del trastorno de ansiedad generalizada

Info

Publication number
AR060349A1
AR060349A1 ARP070101420A ARP070101420A AR060349A1 AR 060349 A1 AR060349 A1 AR 060349A1 AR P070101420 A ARP070101420 A AR P070101420A AR P070101420 A ARP070101420 A AR P070101420A AR 060349 A1 AR060349 A1 AR 060349A1
Authority
AR
Argentina
Prior art keywords
agomelatine
treatment
anxiety disorder
generalized anxiety
medicines
Prior art date
Application number
ARP070101420A
Other languages
English (en)
Spanish (es)
Inventor
Bruno Delalleau
Elisabeth Mocaer
Agnes Fabiano
Mark Millan
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37308935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR060349(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR060349A1 publication Critical patent/AR060349A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP070101420A 2006-04-07 2007-04-04 Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del trastorno de ansiedad generalizada AR060349A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603083A FR2899472B1 (fr) 2006-04-07 2006-04-07 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee

Publications (1)

Publication Number Publication Date
AR060349A1 true AR060349A1 (es) 2008-06-11

Family

ID=37308935

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101420A AR060349A1 (es) 2006-04-07 2007-04-04 Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del trastorno de ansiedad generalizada

Country Status (44)

Country Link
US (1) US7960438B2 (de)
EP (1) EP1842535B1 (de)
JP (1) JP4880031B2 (de)
KR (1) KR20070100657A (de)
CN (1) CN101049290B (de)
AP (1) AP2488A (de)
AR (1) AR060349A1 (de)
AT (1) ATE477798T1 (de)
AU (1) AU2007201527B2 (de)
BR (1) BRPI0701601A (de)
CA (1) CA2584060C (de)
CO (1) CO5840252A1 (de)
CR (1) CR9019A (de)
CY (1) CY1111287T1 (de)
DE (1) DE602007008494D1 (de)
DK (1) DK1842535T3 (de)
EA (1) EA012608B1 (de)
ES (1) ES2351062T3 (de)
FR (1) FR2899472B1 (de)
GE (1) GEP20094743B (de)
GT (1) GT200700032A (de)
HK (1) HK1108367A1 (de)
HR (1) HRP20100577T1 (de)
IL (1) IL182407A (de)
JO (1) JO3440B1 (de)
MA (1) MA28987B1 (de)
ME (1) ME01865B (de)
MX (1) MX2007004100A (de)
MY (1) MY143269A (de)
NI (1) NI200700084A (de)
NO (1) NO20071774L (de)
NZ (1) NZ554347A (de)
PE (1) PE20080174A1 (de)
PL (1) PL1842535T3 (de)
PT (1) PT1842535E (de)
RS (1) RS51485B (de)
SA (1) SA07280161B1 (de)
SG (1) SG136881A1 (de)
SI (1) SI1842535T1 (de)
TN (1) TNSN07118A1 (de)
TW (1) TWI374736B (de)
UY (1) UY30262A1 (de)
WO (1) WO2007116136A1 (de)
ZA (1) ZA200702865B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
CN101585779B (zh) * 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用
FR2956031B1 (fr) * 2010-02-11 2012-03-02 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
PH12012000132A1 (en) * 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
HUE036989T2 (hu) 2013-06-06 2018-08-28 Zentiva Ks Agomelatin készítmény, amely agomelatint ko-kristály formájában tartalmaz
EP2810647A1 (de) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmazeutische Formulierungen, enthaltend Agomelatin in der Form des Co-Kristalls von Agomelatin mit organischer Säure
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
CN110867197A (zh) * 2019-10-23 2020-03-06 吴杰 语音交互过程中实时打断语音机器人的方法及设备

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5737438A (en) * 1994-03-07 1998-04-07 International Business Machine Corp. Image processing
DE19532842C1 (de) * 1995-09-05 1996-12-19 Ibm Bildaufnahmesystem
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
US20050164987A1 (en) * 2003-12-24 2005-07-28 Barberich Timothy J. Melatonin combination therapy for improving sleep quality
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
JP2008531714A (ja) * 2005-03-04 2008-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 不安障害の治療用及び／又は予防用の医薬組成物
US7635721B2 (en) * 2005-08-03 2009-12-22 Les Laboratoires Servier Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200735878A (en) * 2005-11-18 2007-10-01 Astrazeneca Ab Pharmaceutical compositions

Also Published As

Publication number Publication date
PL1842535T3 (pl) 2011-01-31
EP1842535B1 (de) 2010-08-18
MX2007004100A (es) 2009-02-16
NO20071774L (no) 2007-10-08
TW200808295A (en) 2008-02-16
CN101049290A (zh) 2007-10-10
WO2007116136A1 (fr) 2007-10-18
CA2584060C (fr) 2011-04-26
ZA200702865B (en) 2008-07-30
SI1842535T1 (sl) 2010-10-29
ES2351062T3 (es) 2011-01-31
US20070238792A1 (en) 2007-10-11
RS51485B (en) 2011-04-30
AU2007201527A1 (en) 2007-10-25
JO3440B1 (ar) 2019-10-20
SA07280161B1 (ar) 2010-10-23
CN101049290B (zh) 2012-10-31
FR2899472B1 (fr) 2008-09-12
JP2009532446A (ja) 2009-09-10
AU2007201527B2 (en) 2012-08-09
CO5840252A1 (es) 2007-12-31
PE20080174A1 (es) 2008-03-29
GEP20094743B (en) 2009-07-27
IL182407A0 (en) 2008-01-20
NI200700084A (es) 2008-04-24
ATE477798T1 (de) 2010-09-15
BRPI0701601A (pt) 2007-12-11
HK1108367A1 (en) 2008-05-09
MA28987B1 (fr) 2007-11-01
MY143269A (en) 2011-04-15
HRP20100577T1 (hr) 2010-11-30
KR20070100657A (ko) 2007-10-11
CY1111287T1 (el) 2015-08-05
NZ554347A (en) 2008-08-29
CR9019A (es) 2008-10-28
EA200700574A2 (ru) 2007-10-26
TNSN07118A1 (fr) 2008-06-02
AP2007003953A0 (en) 2007-04-30
JP4880031B2 (ja) 2012-02-22
DK1842535T3 (da) 2010-11-15
EA012608B1 (ru) 2009-10-30
US7960438B2 (en) 2011-06-14
AP2488A (en) 2012-10-03
CA2584060A1 (fr) 2007-10-07
EA200700574A3 (ru) 2007-12-28
ME01865B (me) 2011-04-30
FR2899472A1 (fr) 2007-10-12
GT200700032A (es) 2007-10-31
DE602007008494D1 (de) 2010-09-30
EP1842535A1 (de) 2007-10-10
SG136881A1 (en) 2007-11-29
UY30262A1 (es) 2007-05-31
PT1842535E (pt) 2010-09-28
TWI374736B (en) 2012-10-21
IL182407A (en) 2016-02-29

Similar Documents

Publication Publication Date Title
AR060349A1 (es) Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del trastorno de ansiedad generalizada
AR056063A1 (es) Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento de trastornos del sueno en el paciente deprimido
ECSP099476A (es) Compuestos carboxamida y su uso como inhibidores de calpaína
EA201200728A1 (ru) Новые сокристаллы агомелатина, способ их получения и фармацевтические композиции, которые их содержат
CY1112718T1 (el) Ν- (2-υδροξυαιθυλ) -ν-μεθυλ-4- (κινολιν-8-υλ (1- (θειαζολ-4-υλμεθυλ) πιπεριδιν- 4 -υλιδενο) μεθυλ) βενζαμιδιο, η μεθοδος παρασκευης του καθως και η χρηση του για τη θεραπευτικη αγωγη πονου, αγχους και καταθλιψης
AR063896A1 (es) Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del sindrome de smith magenis
UY29470A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos bipolares
AR080150A1 (es) Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del trastorno obsesivo compulsivo (toc)
GT201000100A (es) Productos quimioterapéuticos cristalinos
ECSP10010175A (es) Productos quimioterapéuticos cristalinos
RS51494B (en) THE USE OF AGOMELATIN FOR OBTAINING MEDICINES FOR THE TREATMENT OF PERIVENTRICULAR LEUKOMALATION
UA112407C2 (uk) Співкристали агомелатіну, спосіб їх виготовлення і фармацевтичні композиції, що їх містять
CU20070070A7 (es) Composición farmacéutica de agomelatina
CU20070232A7 (es) Utilización de la agomelatina para la obtención de medicamentos destinados al tratamiento de los trastornos bipolares
EA200601450A1 (ru) Новая комбинация агомелатина и тиморегулирующего средства и фармацевтические композиции, которые её содержат
TH99000A (th) การใช้อะโกมีลาทีนเพื่อให้ได้เวชภัณฑ์ที่มุ่งหมายสำหรับการรักษาเพอริเวนตริคูลาร์ ลิวโคมาลาเซีย
TH97711B (th) การใช้อะโกมีลาทีนในการทำให้มาถึงเวชภัณฑ์ที่มุ่งหมายสำหรับการรักษา Smith-Magenis ซินโดรม
TH87502B (th) การใช้ของอะโกเมลาทีนในการได้รับเภสัชภัณฑ์ที่ถูกมุ่งหมายสำหรบการรักษาของความผิดปกติในการนอนหลับผู้ช่วยที่ซึมเศร้า
TH137776A (th) การใช้แอโกเมลาตินในการผลิตยารักษาโรคซึ่งใช้ในการรักษาความผิดปกติด้านความวิตกกังวลในสภาพโดยทั่วไป
TH97711A (th) การใช้อะโกมีลาทีนในการทำให้มาถึงเวชภัณฑ์ที่มุ่งหมายสำหรับการรักษา Smith-Magenis ซินโดรม
CL2007002789A1 (es) Forma cristalina de [2-(6-fluor-1h-indol-3-ilsulfanil)bencil]metilamina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos afectivos y depresivos, ansiedad, dolor.

Legal Events

Date Code Title Description
FB Suspension of granting procedure